Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01544361 · ClinicalTrials.gov registry record · Phase 1

A Phase 1 Study to Evaluate the Safety of MEDI7814 in Adult Volunteers

A Phase 1 study of Healthy Subjects, sponsored by MedImmune.

Completed
Registry status
Phase 1
Development phase
125
Enrollment target
1
Study location

NCT01544361 is a Phase 1 study of Healthy Subjects that has completed, run by MedImmune. The registered enrollment target is 125 participants, roughly in line with the 127-participant average among 69 other Healthy Subjects trials with a reported enrollment target. The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01544361, a Phase 1 study of Healthy Subjects, has completed, sponsored by MedImmune.

COMPLETED
Registry status
Phase 1
Development phase
125 participants
Enrollment target
1
Study location

Study Summary

This is a Phase 1 study to evaluate the safety and tolerability of single ascending intravenous doses of MEDI7814 in healthy adult subjects.

Conditions Studied

Healthy Subjects

Interventions

  • OTHER Placebo
  • BIOLOGICAL MEDI7814, 1 MG/KG
  • BIOLOGICAL MEDI7814, 3 MG/KG
  • BIOLOGICAL MEDI7814, 10 MG/KG
  • BIOLOGICAL MEDI7814, 20 MG/KG

Study Locations (1)

Nebraska

  • Research Site - Omaha

Trial Details

FieldValue
Enrollment Target 125 participants
Start Date 2012-01
Est. Completion 2012-09
Phase Phase 1

Sponsor

MedImmune

210 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT01544361

The ClinicalTrials.gov registry entry for NCT01544361 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 125 participants, a figure that helps gauge the scale of data the investigators plan to collect, roughly in line with the 127-participant average among 69 other Healthy Subjects trials with a reported enrollment target. The listed sponsor is MedImmune, which has 210 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Healthy Subjects appearing as the primary indexed condition, and to 5 interventions - of which Placebo is the first listed.

NCT01544361 reports 1 study location spanning 1 distinct geographic area - top geographies include Nebraska.

Frequently Asked Questions

What is clinical trial NCT01544361 about?

NCT01544361 is a clinical study titled "A Phase 1 Study to Evaluate the Safety of MEDI7814 in Adult Volunteers". This is a Phase 1 study to evaluate the safety and tolerability of single ascending intravenous doses of MEDI7814 in healthy adult subjects.

What is the current status of trial NCT01544361?

This trial is currently completed. It is a Phase 1 study. The enrollment target is 125 participants. The study started on 2012-01. Estimated completion is 2012-09.

What conditions does trial NCT01544361 study?

This clinical trial studies the following conditions: Healthy Subjects.

What interventions are being tested in trial NCT01544361?

The interventions under investigation include: Placebo (OTHER), MEDI7814, 1 MG/KG (BIOLOGICAL), MEDI7814, 3 MG/KG (BIOLOGICAL), MEDI7814, 10 MG/KG (BIOLOGICAL), MEDI7814, 20 MG/KG (BIOLOGICAL).

Who is sponsoring clinical trial NCT01544361?

This trial is sponsored by MedImmune, which has 210 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT01544361 being conducted?

This trial has 1 study location across Nebraska. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Healthy Subjects

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Healthy Subjects

All registered trials for this condition

Nebraska

All trials with a study site in Nebraska

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.